Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PAVmed Inc (PAVM)
NASDAQ:PAVM
Holding PAVM?
Track your performance easily
PAVM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.60 - $5.70
Previous Close$1.73
Volume59.94K
Average Volume (3M)82.00K
Market Cap
$17.95M
Enterprise Value$97.79M
Total Cash (Recent Filing)$25.50M
Total Debt (Recent Filing)$50.03M
Price to Earnings (P/E)―
Beta1.77
Next Earnings
Nov 12, 2024EPS Estimate
-$1.05Last Dividend Ex-Date
Jan 11, 2024Dividend YieldN/A
Share Statistics
EPS (TTM)-8.13
Shares Outstanding10,406,433
10 Day Avg. Volume109,316
30 Day Avg. Volume82,000
Standard Deviation0.26
R-Squared0.02
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.22
Price to Sales (P/S)4.69
Price to Cash Flow (P/CF)-0.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue25.54
Enterprise Value/Gross Profit-24.64
Enterprise Value/Ebitda-1.48
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
PAVmed News
PremiumCompany Announcements
PAVmed’s Strategic Overhaul to Secure Nasdaq Compliance
PremiumCompany Announcements
PAVmed Shares Informal Financial Performance Insights
Bulls Say, Bears Say
Bulls Say
CommercializationLucid's high growth and ramp up in commercialization will be a major catalyst for PAVmed’s stock.
Market OpportunityExact Sciences' entry into the market validates the huge market opportunity for EsoGuard.
Regulatory ProgressVeris Health is making progress towards regulatory submission and commercial launch of its implantable monitor.
Bears Say
Financial PerformanceReported a wider GAAP loss per share.
Management GuidanceManagement did not provide forward guidance, indicating potential uncertainty in future performance.
Revenue EstimatesLowering 2024 and 2025 revenue estimates.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PAVM FAQ
What was PAVmed Inc’s price range in the past 12 months?
PAVmed Inc lowest stock price was $0.60 and its highest was $5.70 in the past 12 months.
What is PAVmed Inc’s market cap?
Currently, no data Available
When is PAVmed Inc’s upcoming earnings report date?
PAVmed Inc’s upcoming earnings report date is Nov 12, 2024 which is in 53 days.
How were PAVmed Inc’s earnings last quarter?
PAVmed Inc released its earnings results on Aug 13, 2024. The company reported -$1.19 earnings per share for the quarter, beating the consensus estimate of -$1.453 by $0.263.
Is PAVmed Inc overvalued?
According to Wall Street analysts PAVmed Inc’s price is currently Overvalued.
Does PAVmed Inc pay dividends?
PAVmed Inc pays a Notavailable dividend of $0.55 which represents an annual dividend yield of N/A. See more information on PAVmed Inc dividends here
What is PAVmed Inc’s EPS estimate?
PAVmed Inc’s EPS estimate is -$1.05.
How many shares outstanding does PAVmed Inc have?
PAVmed Inc has 10,406,433 shares outstanding.
What happened to PAVmed Inc’s price movement after its last earnings report?
PAVmed Inc reported an EPS of -$1.19 in its last earnings report, beating expectations of -$1.453. Following the earnings report the stock price went down -7.5%.
Which hedge fund is a major shareholder of PAVmed Inc?
Among the largest hedge funds holding PAVmed Inc’s share is Cruiser Capital Advisors, Llc. It holds PAVmed Inc’s shares valued at N/A.
---
PAVmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
PAVM Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 4.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 0.3%
Last 30 Days ▼ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.98%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-26.58%
Trailing 12-Months
Company Description
PAVmed Inc
PAVmed, Inc. is a medical device company, which develops and commercializes a pipeline of medical products. Its product portfolio includes DisappEAR, PORTIO, Caldus, Carpx, NextCath, and NextFlo. The company was founded on June 26, 2014 and is headquartered in New York, NY.
---
PAVM Earnings Call
Q2 2024
0:00 / 0:00
---
PAVM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering PAVM
1 Year
1 Year Success Rate
4/21 ratings generated profit
1 Year Average Return
-22.28%
reiterated a buy rating last month
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 19.05% of your transactions generating a profit, with an average return of -22.28% per trade.
---